TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
– Accomplished industry veteran brings deep strategic and operational expertise ...
Stay updated with breaking news from Salus Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Accomplished industry veteran brings deep strategic and operational expertise ...
Operator: Good morning. And welcome to TriSalus Life Sciences Fourth Quarter and Full Year 2023 Earnings Conference Call. Currently, all participants are on a listen-only mode.
TriSalus Life Sciences, Inc. (TLSI) reported Loss for fourth quarter of -$36.309 million The company's bottom line totaled -$36.309 million, or -$1.56 per share.
– New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic cancer supports further development of the novel TriSalus Infusion System for therapeutic delivery...